Definium Therapeutics, Inc. Operating Cash Flow
Definium Therapeutics, Inc. (DFTX) reported Operating Cash Flow of -$95.41 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Definium Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$52.78M.
- Definium Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$42.63M.
- Definium Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$42.98M.
- Definium Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$29.57M.
- Definium Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$131.56M.
- Definium Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$79.13M.
- Definium Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$64.36M.
- Definium Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$50.14M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 7 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$52.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$95.41M 10-Q · filed 2026-08-06 | -$138.38M derived: sum of 3 quarters · filed 2026-08-06 | -$167.95M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$42.63M 10-Q · filed 2026-05-07 | -$85.61M derived: sum of 2 quarters · filed 2026-05-07 | -$115.17M derived: sum of 3 quarters · filed 2026-05-07 | -$144.77M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$42.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$72.54M derived: sum of 2 quarters · filed 2026-02-26 | -$102.14M derived: sum of 3 quarters · filed 2026-08-06 | -$131.56M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$29.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$59.17M derived: sum of 2 quarters · filed 2026-08-06 | -$88.58M 10-Q · filed 2025-11-06 | -$113.94M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$29.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$59.02M 10-Q · filed 2026-08-06 | -$84.37M derived: sum of 3 quarters · filed 2026-08-06 | -$101.56M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$29.42M 10-Q · filed 2026-05-07 | -$54.77M derived: sum of 2 quarters · filed 2026-05-07 | -$71.96M derived: sum of 3 quarters · filed 2026-05-07 | -$91.95M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | -$25.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$42.54M derived: sum of 2 quarters · filed 2026-02-26 | -$62.53M derived: sum of 3 quarters · filed 2026-02-26 | -$79.13M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$17.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$37.18M derived: sum of 2 quarters · filed 2025-11-06 | -$53.78M 10-Q · filed 2025-11-06 | -$74.34M derived: sum of 4 quarters · filed 2025-11-06 | |
| 2024-06-30 | -$19.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$36.59M 10-Q · filed 2025-07-31 | -$57.15M derived: sum of 3 quarters · filed 2025-07-31 | -$73.78M derived: sum of 4 quarters · filed 2025-07-31 | |
| 2024-03-31 | -$16.60M 10-Q · filed 2025-05-08 | -$37.16M derived: sum of 2 quarters · filed 2025-05-08 | -$53.79M derived: sum of 3 quarters · filed 2025-05-08 | -$67.63M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$20.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$37.19M derived: sum of 2 quarters · filed 2025-03-06 | -$51.03M derived: sum of 3 quarters · filed 2025-03-06 | -$64.36M 10-K · filed 2025-03-06 | |
| 2023-09-30 | -$16.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$30.47M derived: sum of 2 quarters · filed 2024-11-07 | -$43.80M 10-Q · filed 2024-11-07 | -$56.65M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | -$13.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$27.18M 10-Q · filed 2024-08-13 | -$40.02M derived: sum of 3 quarters · filed 2024-08-13 | -$49.32M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | -$13.33M 10-Q · filed 2024-05-08 | -$26.18M derived: sum of 2 quarters · filed 2024-05-08 | -$35.48M derived: sum of 3 quarters · filed 2024-05-08 | -$50.60M derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | -$12.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$22.15M derived: sum of 2 quarters · filed 2024-02-28 | -$37.27M derived: sum of 3 quarters · filed 2024-02-28 | -$50.14M 10-K · filed 2024-02-28 | |
| 2022-09-30 | -$9.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$24.42M derived: sum of 2 quarters · filed 2023-11-02 | -$37.29M 10-Q · filed 2023-11-02 | -$45.12M derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | -$15.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$27.99M 10-Q · filed 2023-08-03 | -$35.83M derived: sum of 3 quarters · filed 2023-08-03 | -$52.61M derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | -$12.87M 10-Q · filed 2023-05-04 | -$20.70M derived: sum of 2 quarters · filed 2023-05-04 | -$37.48M derived: sum of 3 quarters · filed 2023-05-04 | -$48.65M derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | -$7.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$24.61M derived: sum of 2 quarters · filed 2023-03-09 | -$35.79M derived: sum of 3 quarters · filed 2023-03-09 | -$45.82M 10-K · filed 2023-03-09 | |
| 2021-09-30 | -$16.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$27.95M derived: sum of 2 quarters · filed 2022-11-10 | -$37.99M 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$11.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$21.21M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | -$10.04M 10-Q · filed 2022-05-16 | ||||
| 2020-12-31 | -$23.60M 10-K · filed 2022-03-28 | ||||
| 2019-12-31 | -$3.20M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |